Europe Blood Plasma Derivatives Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Blood Plasma Derivatives Market – by Type

1.3.2 Europe Blood Plasma Derivatives Market – by Application

1.3.3 Europe Blood Plasma Derivatives Market – by End User

1.3.4 Europe Blood Plasma Derivatives Market – by Country

2. Europe Blood Plasma Derivatives Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Blood Plasma Derivatives Market – Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

4.3 Expert’s Opinion

5. Europe Blood Plasma Derivatives Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Blood Disorders

5.1.2 Rise in Geriatric Population

5.2 Market Restraints

5.2.1 Complicated Reimbursement Policies

5.3 Market Opportunities

5.3.1 Incorporation of Platelet-Rich Plasma in Regenerative Medicine

5.4 Future Trends

5.4.1 Increasing Usage of Immunoglobulin G in Multiple Treatments

5.5 Impact Analysis

6. Blood Plasma Derivatives Market – Europe Analysis

6.1 Europe: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7. Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – by Type

7.1 Overview

7.2 Europe Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)

7.3 Albumin

7.3.1 Overview

7.3.2 Albumin: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Factor VIII

7.4.1 Overview

7.4.2 Factor VIII: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Factor IX

7.5.1 Overview

7.5.2 Factor IX: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Immunoglobulin

7.6.1 Overview

7.6.2 Immunoglobulin: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.3 IgG

7.6.3.1 Overview

7.6.3.2 IgG: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.4 IgM

7.6.4.1 Overview

7.6.4.2 IgM: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.5 IgA

7.6.5.1 Overview

7.6.5.2 IgA: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.6 IgD

7.6.6.1 Overview

7.6.6.2 IgD: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.7 IgE

7.6.7.1 Overview

7.6.7.2 IgE: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Hyperimmune Globulin

7.7.1 Overview

7.7.2 Hyperimmune Globulin: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.8 Others

7.8.1 Overview

7.8.2 Others: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8. Europe Blood Plasma Derivatives Market Analysis and Forecasts to 2028 – by Application

8.1 Overview

8.2 Europe Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)

8.3 Hemophilia

8.3.1 Overview

8.3.2 Hemophilia: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Hypogammaglobulinemia

8.4.1 Overview

8.4.2 Hypogammaglobulinemia: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Immunodeficiency Diseases

8.5.1 Overview

8.5.2 Immunodeficiency Diseases: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Von Willebrand Disease

8.6.1 Overview

8.6.2 Von Willebrand Disease: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Other Applications

8.7.1 Overview

8.7.2 Other Applications: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – by End User

9.1 Overview

9.2 Europe Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Clinics

9.4.1 Overview

9.4.2 Clinics: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Other End Users

9.5.1 Overview

9.5.2 Other End Users: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – Country Analysis

10.1 Overview

10.1.1 Europe: Blood Plasma Derivatives Market, by Country, 2021 & 2028 (%)

10.1.1.1 Germany: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 Germany: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3 Germany: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.1.3.1 Germany: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.1.4 Germany: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.1.5 Germany Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

10.1.1.2 France: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 France: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3 France: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.2.3.1 France: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.2.4 France: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.2.5 France Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

10.1.1.3 Italy: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 Italy: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3 Italy: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.3.3.1 Italy: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.3.4 Italy: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.3.5 Italy Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

10.1.1.4 Spain: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 Spain: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3 Spain: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.4.3.1 Spain: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.4.4 Spain: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.4.5 Spain Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

10.1.1.5 United Kingdom: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Overview

10.1.1.5.2 United Kingdom: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3 United Kingdom: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.5.3.1 United Kingdom: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.5.4 United Kingdom: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.5.5 United Kingdom Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

10.1.1.6 Rest of Europe: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Europe: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3 Rest of Europe: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.6.3.1 Rest of Europe: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.6.4 Rest of Europe: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.6.5 Rest of Europe Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Blood Plasma Derivatives Market

11.3 Inorganic Growth Strategies

11.3.1 Overview

11.4 Organic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Grifols SA

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 SK Plasma Co Ltd

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Octapharma AG

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Monobind Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Intas Pharmaceuticals Ltd

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Fusion Health Care Pvt Ltd

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Takeda Pharmaceutical Co Ltd

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 CSL Behring LLC

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 LFB SA

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Kedrion SpA

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. Germany Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 2. Germany Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 3. Germany Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 4. Germany Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 5. France Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 6. France Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 7. France Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 8. France Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 9. Italy Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 10. Italy Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 11. Italy Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 12. Italy Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13. Spain Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 14. Spain Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 15. Spain Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 16. Spain Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17. United Kingdom Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 18. United Kingdom Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 19. United Kingdom Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 20. United Kingdom Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 21. Rest of Europe Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 22. Rest of Europe Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 23. Rest of Europe Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 24. Rest of Europe Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 25. Recent Inorganic Growth Strategies in the Blood Plasma Derivatives Market

Table 26. Recent Organic Growth Strategies in the Blood Plasma Derivatives Market

Table 27. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Blood Plasma Derivatives Market Segmentation

Figure 2. Europe Blood Plasma Derivatives Market, by Country

Figure 3. Europe Blood Plasma Derivatives Market Overview

Figure 4. Immunoglobulin Segment Held Largest Share of Type Segment in Europe Blood Plasma Derivatives Market

Figure 5. Germany is Expected to Show Remarkable Growth During Forecast Period

Figure 6. Europe: PEST Analysis

Figure 7. Experts’ Opinion

Figure 8. Blood Plasma Derivatives Market: Impact Analysis of Drivers and Restraints

Figure 9. Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. Europe Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)

Figure 11. Albumin: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Factor VIII: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Factor IX: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Immunoglobulin: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. IgG: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. IgM: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. IgA: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. IgD: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. IgE: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Hyperimmune Globulin: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Others: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Europe Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)

Figure 23. Hemophilia: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Hypogammaglobulinemia: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Immunodeficiency Diseases: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Von Willebrand Disease: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Other Applications: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Europe Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)

Figure 29. Hospitals: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Clinics: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Other End Users: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Europe: Blood Plasma Derivatives Market, by Key Country – Revenue (2021) (US$ Million)

Figure 33. Germany: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. France: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Italy: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. Spain: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37. United Kingdom: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38. Rest of Europe: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39. Growth Strategies in the Blood Plasma Derivatives Market